| Spectrumedix Corporation | |||
| Proposed Ticker: | SMDX | 2124 Old Gatesburg Road | |
| Exchange: | NASDAQ-Small Cap Market | State College, PA 16803 | |
| Industry: | Manufacturing (SIC Code 3826) | (814) 867-8600 | |
| Type of Shares: | Common Shares | Filing Date: | 3/18/97 | |
| U.S. Shares Filed: | 1,600,000 | Filing Price: | $5.00 | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $8,000,000 | |
| Primary Shares: | 1,600,000 | Expenses: | $690,000 | |
| Secondary Shares: | 0 | Shares Out After: | 4,094,534 |
| Manager | Tier | Phone |
| Patterson Travis, Inc. | Lead Manager | (212) 837-7340 |
| Issuer's Law Firm: | Brobeck, Phleger & Harrison |
| Bank's Law Firm: | Bernstein & Wasserman |
Dollar amounts in U.S. millions except for per share data | |||||
| 9 Month Ending Financials | |||||
| Full Year Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 3/31/96 | 12/31/96 | 12/31/95 | 12/31/96 | ||
| Revenue: | $0.65 | $0.31 | $0.57 | Assets: | $0.25 |
| Net Income: | -$0.87 | -$1.75 | -$0.51 | Curr Assets: | $0.08 |
| EPS: | -$0.35 | -$0.70 | -$0.20 | Liabilities: | $2.29 |
| Prior EPS: | -$0.25 | Curr Liabilities: | $2.29 | ||
| Cash Flow/Oper: | Equity: | -$2.04 | |||
| Cash Flow/Fin: | Cash: | $0.02 | |||
| Cash Flow/Inv: | Working Cap: | -$2.20 | |||
| Business Description |
| The company has a strong focus on medical and scientific technologies and associated instrumentation. It manufactures nearly the entire range of magnetic sector mass spectrometers, as well as other analytical instruments and software packages. The company's existing instruments are characterized by their capacity to accurately detect minute traces of elements and compounds and to perform the compositional measurements for specific medical, biological, industrial, chemical, geological and scientific applications. Using its expertise in analytical instrumentation, the company is engaged in two research and development programs to expand its product base. The first program, developed in part from research efforts conducted at the United States Department of Energy. The second program, a result of initial research conducted at the University of California, Berkeley, involves the development of analytical instruments which utilize a process referred to as diagnostic kinetics to diagnose, monitor and assist in the treatment of serious diseases. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used for repayment of debt, research and development, working capital, facilities, machinery and equipment. |